Your Sorted CME/CE Activities

Conversations in PAH: COVID-19 & PAH, Current and Emerging Treatments
This AMA/ANCC/ACPE activity features a recorded discussion among three experts and is designed to keep healthcare professionals on top of the most recent clinical findings in PAH.

The first edition will feature Dr. Ronald Oudiz, Dr. Murali Chakinala and Dr. Harrison Farber discussing updates on COVID-19 & PAH and recent treatment strategies of PAH and emerging research for 2021.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.

Ronald Oudiz, MD Ronald Oudiz, MD, FACP, FACC, FCCP
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
Lundquist Institute at Harbor-UCLA Medical Center
Expert Faculty:
 Murali Chakinala, MD, FCCP Murali Chakinala, MD, FCCP
Professor of Medicine
Washington University School of Medicine
Staff Physician
Barnes-Jewish Hospital
 Harrison Farber, MD Harrison Farber, MD
Professor of Medicine Tufts Medical Center, Boston, MA

Supported by independent educational grants from United Therapeutics Corporation, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson

Launch Date: May 3, 2021
Release Date: April 12, 2021
Expiration Date: April 30, 2022

April 30, 2022
Mini Module